Intra-Cellular Therapies Highlights Data Presentations at the American Society of Clinical ...

NEW YORK, May 23, 2024 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders,

Related Keywords

Ukraine ,Miami ,Florida ,United States ,American ,Cameron Radinovic Lee Roth ,Juan Sanchez ,Cellular Therapies Inc ,Burns Mcclellan Inc ,Exchange Commission ,American Society Of Clinical Psychopharmacology ,Corporate Communications ,Nasdaq ,Cellular Therapies ,American Society ,Clinical Psychopharmacology ,Annual Meeting ,Patients With Major Depressive Disorder ,Bipolar Disorder ,Anxious Distress ,Major Depressive Disorder ,Bipolar Depression With Mixed Features ,Efficacy Across ,Lumateperone Treatment ,Major Depressive Episodes ,Mixed Features ,Adverse Reactions ,Elderly Patients ,Dementia Related Psychosis ,Boxed Warning ,Malignant Syndrome ,Blood Pressure ,Private Securities Litigation Reform Act ,Intra Cellular Therapies ,